NEW YORK, NY and SAN DIEGO, CA / ACCESSWIRE / February 21, 2024 / Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential claims on behalf of purchasers of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL).
The focus of the investigation is whether the Company issued false and/or misleading statements and/or did not disclose information pertinent to investors.
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
On February 13, 2024, QuidelOrtho issued a press release announcing its fourth quarter and full-year 2023 financial results. Among other items, QuidelOrtho reported non-GAAP earnings per share of $1.17, missing consensus estimates by $0.89, and revenue of $742.6 million, missing consensus estimates by $44.86 million. QuidelOrtho's disappointing financial results prompted downgrades by analysts at J.P. Morgan and William Blair.
On this news, QuidelOrtho's stock price fell $21.50 per share, or 32.2%, to close at $45.27 per share on February 14, 2024.
Wolf Haldenstein has experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in New York, Chicago, Nashville, and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly lauded by the courts, which have appointed it to major positions in complex securities, multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735 or via e-mail at [email protected].
CONTACT:
Wolf Haldenstein Adler Freeman & Herz LLP
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
SOURCE: Wolf Haldenstein Adler Freeman & Herz LLP